|
|
Zealand Pharma A/S
CPH •
Healthcare •
Biotechnology •
Quote as of 06/08/2026 11:24
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCPH
Market Capitalization22,406 mln
Float56.75 mln
Earnings Date05/07/2026
P / E
2.82
Deeply undervalued
1-Year Forecast
519
Transformational upside
Key Fundamentals
EPS89.39
P/E2.82
ROE46.77
RPS129
ROIC1,514
ROA43.02
Interest Cover264
EBITDA, mln7,003
EV / EBITDA1.47
EV / EBIT1.48
Revenue, mln9,241
EV / Revenue1.12
Financial Strength
Altman Z-Score20.79
Piotroski F-Score
8
/ 9
Beneish M-Score145
Price to Intrinsic Value1.62
Price to Graham Number0.49
1-Year Target Price519
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-21.58% |
0
/ 100
 |
| 1 Month |
-14.75% |
2
/ 100
|
| 2 Months |
-32.65% |
2
/ 100
|
| 6 Months |
-52.52% |
2
/ 100
|
| 1 Year |
-43.81% |
3
/ 100
|
|
| |
